1
James W Heller, David Lipson, Kirk W Johnson: Thin film electrical component. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, April 28, 1992: US05108819 (432 worldwide citation)

A biocompatible thin film electrical component is configured for use in a human body or other ionic liquid environment. A polyimide substrate is bonded to a glass carrier plate sized for handling by automatic equipment and a multiple-layer metal conductor is deposited on the substrate and patterned ...


2
Dale C Harris: Multiple dose injection pen. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, July 13, 1993: US05226895 (325 worldwide citation)

The present invention relates to a hypodermic syringe having the same general appearance as a pen which is specifically adapted to provide for multiple measured injections of materials such as insulin or human growth hormone.


3
Ramamoorthy Belagaje, Janet K Epp, JoAnn Hoskins, Hansen M Hsiung, George L Long, Brigitte E Schoner: Derivative of the tryptophan operon for expression of fused gene products. Eli Lilly and Company, Ron K Levy, Leroy Whitaker, April 19, 1988: US04738921 (122 worldwide citation)

The present invention comprises improved derivatives of the tryptophan operon useful for expressing fused gene products in E. coli and relate organism. Two of the improved derivatives disclosed are encoded on 0.43 and 0.55 kb EcoRI restriction fragments from plasmids pCZ20 and pLEBGH2 (in strains NR ...


4
Jiban K Chakrabarti, Terrence M Hotten, David E Tupper: 2-methyl-thieno-benzodiazepine. Lilly, Joseph A Jones, Leroy Whitaker, MaCharri R Vorndran Jones, July 20, 1993: US05229382 (117 worldwide citation)

2-Methyl-10-(4-methyl-1-piperazinyl)-4H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##


5

6
Robert F Santerre, Ramachandra N Rao: Recombinant DNA cloning vectors and the eukaryotic and prokaryotic transformants thereof. Eli Lilly and Company, Gerald V Dahling, Leroy Whitaker, February 23, 1988: US04727028 (101 worldwide citation)

The present invention comprises novel recombinant DNA cloning and expression vectors which confer hygromycin B and/or G418 resistance to eukaryotic and prokaryotic host cells. The novel recombinant DNA vectors are derived from plasmid pKC203, a plasmid which can be isolated from E. coli JR225 (ATCC ...


7
Dale C Harris: Multiple dose injection pen. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, May 3, 1994: US05308340 (93 worldwide citation)

The present invention relates to a hypodermic syringe having the same general appearance as a pen which is specifically adapted to provide for multiple measure injections of materials such as insulin or human growth hormone.


8
Dale C Harris: Dose indicating injection pen. Eli Lilly and Company, Douglas J Taylor, Leroy Whitaker, March 22, 1994: US05295976 (89 worldwide citation)

Two embodiments of a multi-dose syringe both include structure for indicating the selected amount of liquid to be injected. A first element and a second element coupled respectively to the syringe housing and the plunger rod are adapted for calibrated movement with respect to each other, one of the ...


9
Ramakrishnan Nagarajan, Amelia A Schabel: Novel glycopeptide derivatives. Eli Lilly and Company, Nancy J Harrison, Leroy Whitaker, October 6, 1987: US04698327 (84 worldwide citation)

Novel glycopeptide antibiotics of formula (I) can be prepared from the glycopeptide antibiotics vancomycin, A51568A, A51568B, M43A and M43D by reaction with a ketone or aldehyde followed, if appropriate, by reduction. The new glycopeptide derivatives are useful antibacterial agents.


10
Peter L Oren, Werner M K Seidler: Sustained release matrix. Eli Lilly and Company, William B Scanlon, Leroy Whitaker, November 6, 1990: US04968508 (81 worldwide citation)

This invention provides a matrix composition for sustained drug delivery which is comprised of an active agent, a hydrophilic polymer and an enteric polymer. The enteric polymer is impermeable to gastric fluids and aids in retarding drug release in regions of low pH, thus allowing lower levels of hy ...